Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 776 results for "ranbaxy"

Sun Pharma looks to divest more assets from Ranbaxy stable

and ease integration issues arising from the mega transaction. ET NOW learns that India's top drugmaker is looking to divest additional assets from the erstwhile Ranbaxy portfolio. "The company is exploring options to further lighten the existing Ranbaxy ... Economic Times, 22 hours ago

8 images for ranbaxy

Times of India, 13 hours ago
Money Control, 1 week ago
DNA, 1 week ago
NDTV, 3 weeks ago
NDTV, 3 weeks ago
NDTV Profit, 3 weeks ago
Money Control, 3 weeks ago
Business Standard India, 1 month ago

1,800 companies legal spend up 18% to $3.5bn - RIL alone billed Rs 1,200 cr, Ranbaxy doubled costs to Rs 850 cr: ET

The Economic Times research arm, the ET Intelligence Group, surveying more than 1,800 listed companies, has revealed that their legal spend was Rs 21,906 crore ($3.5bn) in the 2013-14 financial year, an increase of more than 17.5 per cent on last ...
 Legally India3 days ago
DNA

Sun completes sale of two Ranbaxy divisions to Strides Shasun

The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore Sun Pharmaceutical Industries has completed the process of selling two divisions of erstwhile Ranbaxy Laboratories to Strides ...
 CPhI.cn1 week ago Sun Pharma completes sale of 2 Ranbaxy divisions to Strides for Rs 165 crore  DNA1 week ago Sun completes sale of 2 Ranbaxy divisions to Strides  Money Control1 week ago Sun Pharma gets CCI nod to sell two CNS divisions to Strides  ZeeNews.com3 weeks ago
[x]  

Strides Shasun gains on receiving CCI nod for acquisition of two CNS division of Ranbaxy

SENSEX 24483.37 47.71 0.20% NIFTY 7435.00 12.55 0.17% Industry: Medical/Healthcare Company Strides Shasun Ltd Strides Shasun is currently trading at Rs. 1149.50, up by 15.75 points or 1.39% from its previous closing of Rs.
 Finalaya.com2 weeks ago Strides Shasun surges on receiving CCI nod for acquisition of two CNS division of Ranbaxy  Finalaya.com3 weeks ago Sun Pharma gains on receiving CCI nod for sale of two CNS division to Strides Shasun  Finalaya.com3 weeks ago

Strides Shasun receives CCI approval for acquisition of CNS divisions of Ranbaxy

Strides Shasun Ltd has now informed BSE that that the Company has, on January 21, 2016 received order under the Competition Act, 2002 from the Competition Commission of India (CCI) approving the proposed transaction.
 Money Control3 weeks ago Sun Pharma gets CCI approval for sale of Ranbaxy's CNS divisions to Strides Shasun  Money Control3 weeks ago Strides Shasun gets approval from Competition Commission of India  HDFC Securities3 weeks ago

Sun Pharmaceuticals to sell some low priority Ranbaxy brands

MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country's largest drug maker ...
 Economic Times2 weeks ago
Livemint.com

Petition against Sun Pharma for allegedly violating merger norms

Union claims Sun transferred and demoted some employees belonging to Ranbaxy after acquiring the firm Sun Pharmaceutical Industries Ltd, which acquired Ranbaxy Laboratories Ltd last year, is facing protests from its sales force after the country's ...
 Livemint.com1 month ago Mumbai Court rejects union's claim against Sun Pharmaceutical Industries  Economic Times3 days ago Mumbai Court rejects union’s claim against Sun Pharmaceutical Industries  Economic Times3 days ago

Sun Pharma rises 3%, CLSA retains buy on 72% FY17 EPS growth

CLSA says Sun's FY17 EPS will be driven by Gleevec generic launch in the United States synergy benefits with Ranbaxy that merged with effect from April 2015.
 Money Control1 month ago
International Business Times India

Sun Pharmaceutical: Not a health scare

Troubles with the Halol plant and the Ranbaxy merger should pass The stock of Sun Pharmaceutical Industries has lost nearly 30 per cent in the last eight months. This was on two counts. First, weak performance following consolidation of Ranbaxys numbers ...
 Business Line1 month ago Taro provides cushion for Sun Pharma  Business Standard India17 hours ago Sun Pharma: Taro provides big cushion  Business Standard India19 hours ago Sun Pharma Q3 profit surges 28% despite lower US sales  International Business Times India1 day ago
[x]  

Bionpharma buys 25 products from specialty drug maker Banner Life Sciences

MUMBAI: Bionpharma, a New Jersey-based pharmaceutical startup founded last year by five former Ranbaxy executives and backed by strategic and financial investors, has acquired a portfolio of approximately 25 products from specialty drug maker Banner ...
 Economic Times1 month ago Bionpharma acquires 25 products of Banner Life Sciences  VC Circle1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less